Booting Earth Optimization System
Thank you for your patience. Your civilization is very important to us.
Famotidine (H2 Receptor Blocker)
Treatment for Gastritis and duodenitis
Typical Dosage: 20-40mg once or twice daily
Effectiveness
75%
Safety Score
78%
Clinical Trials
500
Participants
50K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
78
DangerousModerateSafe
Treatment Details
Dosage Range
20-40mg once or twice daily
Time to Effect
Hours for symptom relief, 6-12 weeks for healing
Treatment Duration
6-12 weeks, or longer for maintenance
Evidence Quality
HIGHNumber Needed to Treat (NNT)
6(Treat 6 patients to see 1 additional successful outcome)
Confidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$150
Monitoring:$50
Side Effect Mgmt:$10
Total Annual:$210
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$10,000/QALY
QALYs Gained
0.15
Outcome-Based Costs
Cost per Responder
$280
Cost per Remission
$323
Comparison vs Omeprazole (PPI)
Cost Difference
$-60/year
Less expensive
QALY Difference
-0.05 QALYs
Worse outcomes
Dominance
No dominance
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov